Millennium Pharmaceuticals, a biopharmaceutical company headquartered in Cambridge, MA, is focused on developing drugs in two therapeutic areas: cancer and inflammation.

The company's leading products are:

Velcade (bortezomib). Velcade is the first in a class of medicines called proteasome inhibitors and is used in treating patients with multiple myeloma, a form of cancer that develops in plasma cells, the white blood cells that make antibodies.

*Information above taken from materials provided by Millennium.